SeekingAlpha.com: All News Sarepta Therapeutics is set to replace Shockwave Medical in the S&P MidCap 400 index, effective June 3, according to S&P Dow Jones Indices.\n more…
Seeking Alpha - Healthcare Shockwave Medical gains after HSR waiting period for sale to J&J expires...\n more…
Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Shockwave Medical, Inc. (NasdaqGS: SWAV) to...\n more…